touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
Vizitează neapărat site-ul podcastului și susține-i creatorul: touchpodcast.podbean.com
Autor
touchpodcast
Categorie
Site-ul podcastului
Cel mai nou episod
17 nov. 2026
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
Perspectives on the mechanism linking obesity with T2D 13.10.2021 12:37
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the mechanism linking obesity with T2D and share their observations from the clinic on the course of disease from obesity to T2D. The multidisciplinary team Primary care specialist: Professor Stewart Harris, Canada Endocrinologist: Professor Dr med Michael Nauck, Germany This touchPODCAST is for HCPs only....
MDT and patient perspectives on antihyperglycemic therapies and their association with weight loss 13.10.2021 16:32
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 RAs and SGLT2is and their association with weight loss; plus the patient’s experience of using a GLP-1 RA to manage their T2D and obesity. The multidisciplinary team and patient Endocrinologist: Professor Dr med Michael Nauck, Germany Primary care s...
MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity 13.10.2021 19:43
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapies to achieve an effective combination of glycemic control, weight loss and cardiovascular benefits. The multidisciplinary team and patient Diabetes nurse practitioner: Dr Shannon Idzik, USA Primary care specialist: Professor Stewart Harris, Canada P...
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021 06.10.2021 1:02:47
touchCONGRESS for touchRESPIRATORY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and...
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021 06.10.2021 1:02:43
touchCONGRESS for touchONCOLOGY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and Pr...
Type 2 diabetes experts discuss achieving individualized glycemic targets in patients with T2D 30.09.2021 42:15
touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Vincent Woo in conversation with Dr Joanna Van. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for achieving individualized glycemic targets in patients with type 2 diabetes. This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational g...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3 23.09.2021 13:07
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independen...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 2 23.09.2021 14:50
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review a patient profile and describe how they would determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is f...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 1 23.09.2021 13:18
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for patients with EC. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education g...
Immunotherapy and evolving approaches for basal cell carcinoma 17.09.2021 36:19
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Bo...
Immunotherapy and evolving approaches for basal cell carcinoma 17.09.2021 36:20
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Bost...
What is the long-term picture for patients with EGFR-mutant NSCLC? 15.09.2021 13:38
touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data. The multidisciplinary team Medical oncologist: Dr David Planchard, France Oncology nurse practitioner: Ms Beth Sandy, USA This touchPODCAST is for HCPs only. This act...
What are the implications of adjuvant therapy data on biomarker evaluation? 15.09.2021 14:15
touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC. The multidisciplinary team Medical oncologist: Dr David Planchard, France Molecular pathologist: Prof. Albrecht Stenzinger, Germany This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education gra...
How is the advent of adjuvant therapy in NSCLC changing our approach to surgery? 15.09.2021 16:39
touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options. The multidisciplinary team Medical oncologist: Dr David Planchard, France Pulmonologist: Prof. Johan Vansteenkiste, Belgium Thoracic surgeon: Dr Masahiro Tsuboi, Japan This touchPODCAST is for HCPs onl...
Patient education, evidence-based treatment and biomarkers in HFrEF 29.07.2021 35:42
touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF. The experts Pr...
Highlights from EHA2021 Virtual 2021: Focus on MDS and AML 20.07.2021 1:04:10
touchCONGRESS for touchONCOLOGY Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the improvement of outcomes in higher-risk MDS and newly diagnosed AML, including expert insights and interpretation from Prof. Valeria Santini (Italy) and Prof. Andrew Wei (Australia). This touchPODCAST is for HCPs only. Funding for this touchPOD...
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management 20.07.2021 13:01
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia. The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK This touchPODCAST is for HCPs only. This activity is funded by an...
Perspectives on how novel lipid-lowering therapies may help address current unmet needs 20.07.2021 14:34
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medic...
Perspectives on the latest data for novel lipid-lowering therapies 20.07.2021 19:02
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only....
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management 20.07.2021 13:06
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK This touchPODCAST is for HCPs only. This activity is funded...
Perspectives on how novel lipid-lowering therapies may help address current unmet needs 20.07.2021 14:41
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independen...
Perspectives on the latest data for novel lipid-lowering therapies 20.07.2021 19:07
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only....
HR+/HER2- advanced breast cancer: How do the latest data on CDK4/6 inhibitors inform clinical decision-making? 30.06.2021 39:06
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts in breast cancer share their opinion on the latest data which may help guide the use of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer. The experts Dr Luca Malorni - Hospital of Prato, Italy Prof. Aleix Prat - Hospital Clínic Barcelona, Spain Dr Barbara Pistilli - Gustave Roussy, Villejuif, France This touchPODCAST is for HCPs...
Paving the way for optimal disease control in moderate-to-severe type 2 asthma 26.04.2021 30:21
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and...
Paving the way for optimal disease control in moderate-to-severe type 2 asthma 22.04.2021 30:20
touchPANEL DISCUSSION for touchRESPIRATORY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice